Publikationen von Eva-Maria Mandelkow
Alle Typen
Zeitschriftenartikel (26)
1.
Zeitschriftenartikel
1184, S. 97 - 103 (2019)
Presynaptic Pathophysiology Encoded in Different Domains of Tau - Hyper-Versus Hypoexcitability? Advances in Experimental Medicine and Biology 2.
Zeitschriftenartikel
14, 13 (2019)
Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer's disease mouse model. Molecular Neurodegeneration 3.
Zeitschriftenartikel
56 (5), S. 3751 - 3767 (2019)
Suppressing Tau aggregation and toxicity by an anti-aggregant Tau fragment. Molecular Neurobiology 4.
Zeitschriftenartikel
117, S. 189 - 202 (2018)
Glutamatergic nervous system degeneration in a C. elegans TauA152T tauopathy model involves pathways of excitotoxicity and Ca2+ dysregulation. Neurobiology of Disease 5.
Zeitschriftenartikel
18 (5), S. 3271 - 3281 (2018)
Reversible cation-selective attachment and self-assembly of human Tau on supported brain lipid membranes. Nano Letters 6.
Zeitschriftenartikel
12, 88 (2017)
Anti-aggregant tau mutant promotes neurogenesis. Molecular Neurodegeneration 7.
Zeitschriftenartikel
57, S. 47 - 63 (2017)
Time course of Tau toxicity and pharmacologic prevention in a cell model of Tauopathy. Neurobiology of Aging 8.
Zeitschriftenartikel
5, 91 (2017)
Atypical, non-standard functions of the microtubule associated Tau protein. Acta Neuropathologica Communications 9.
Zeitschriftenartikel
292 (29), S. 12192 - 12207 (2017)
Axodendritic sorting and pathological missorting of Tau are isoform-specific and determined by axon initial segment architecture. The Journal of Biological Chemistry 10.
Zeitschriftenartikel
1523, S. 335 - 340 (2017)
Tracking Tau in neurons: How to transfect and track exogenous tau into primary neurons. Methods in Molecular Biology 11.
Zeitschriftenartikel
1523, S. 327 - 334 (2017)
Tracking Tau in neurons: How to grow, fix, and stain primary neurons for the investigation of Tau in all developmental stages. Methods in Molecular Biology 12.
Zeitschriftenartikel
17 (4), S. 552 - 569 (2016)
The Tau/A152T mutation, a risk factor for frontotemporal-spectrum disorders, leads to NR2B receptor-mediated excitotoxicity. EMBO Reports 13.
Zeitschriftenartikel
113 (41), S. 11597 - 11602 (2016)
Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau δK280. Proceedings of the National Academy of Sciences of the United States of America 14.
Zeitschriftenartikel
36, 1592, S. 52 - 58 (2016)
Tau neurotoxicity and rescue in animal models of human Tauopathies. Current Opinion in Neurobiology 15.
Zeitschriftenartikel
11 (1), 96 (2016)
Tau mutant A152T, a risk factor for FTD/PSP, induces neuronal dysfunction and reduced lifespan independently of aggregation in a C. elegans Tauopathy model. Molecular Neurodegeneration 16.
Zeitschriftenartikel
4, 17 (2016)
Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD. Acta Neuropathologica Communications 17.
Zeitschriftenartikel
12 (9), S. 814 - 828 (2015)
Identification of small molecule inhibitors of tau aggregation by targeting monomeric tau as a potential therapeutic approach for tauopathies. Current Alzheimer Research 18.
Zeitschriftenartikel
44 (3), S. 937 - 947 (2015)
Carboxy terminus heat shock protein 70 interacting protein reduces tau-associated degenerative changes. Journal of Alzheimer's Disease 19.
Zeitschriftenartikel
6, 7025 (2015)
A mechanistic model of tau amyloid aggregation based on direct observation of oligomers. Nature Communications 20.
Zeitschriftenartikel
289 (29), S. 20318 - 20332 (2014)
Stages and conformations of the Tau repeat domain during aggregation and its effect on neuronal toxicity. Journal of Biological Chemistry